Russell Investments Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Sell |
5,101
-53
| -1% | -$356 | ﹤0.01% | 3071 |
|
|
2025
Q1 | $46.6K | Buy |
5,154
+334
| +7% | +$3.02K | ﹤0.01% | 2926 |
|
|
2024
Q4 | $83.3K | Buy |
4,820
+4,811
| +53,456% | +$83.2K | ﹤0.01% | 2721 |
|
|
2024
Q3 | $144 | Sell |
9
-2,051
| -100% | -$32.8K | ﹤0.01% | 3659 |
|
|
2024
Q2 | $29.4K | Buy |
2,060
+2,051
| +22,789% | +$29.2K | ﹤0.01% | 2880 |
|
|
2024
Q1 | $128 | Hold |
9
| – | – | ﹤0.01% | 3292 |
|
|
2023
Q4 | $136 | Hold |
9
| – | – | ﹤0.01% | 3192 |
|
|
2023
Q3 | $142 | Sell |
9
-6,744
| -100% | -$106K | ﹤0.01% | 3507 |
|
|
2023
Q2 | $102K | Buy |
+6,753
| New | +$102K | ﹤0.01% | 2599 |
|